Non ionic surfactant vesicles (nisvs) as a drug delivery and targeting systems for antimicrobials
Active Definitive Contract Awarded Last action
- Contract number
- HDTRA122C0032
- Awardee
-
Ministry Of Defence UEI U6LDUQKZ2CS8
- Awarding agency
-
Defense Threat Reduction Agency
Department of Defense
- Obligated
- $5,500,449
Award facts
- Opportunity
-
- Science and Technology New Initiatives BAA Solicitation · HDTRA117S0002 · Posted Nov 2, 2016
- Contract value 86% obligated
- $6,400,448.87 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Great Britain, United Kingdom
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $239,782 | |
| Funding Only Action | $650,000 | |
| Funding Only Action | $400,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $712,653 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,429,633 | |
| Funding Only Action | $1,260,213 | |
| Funding Only Action | $608,168 | |
| Original award | $200,000 |
Show all 11
About this award
The Defense Threat Reduction Agency awarded a $6.4 million definitive contract to the Ministry of Defence, operating as Defence Science and Technology Laboratory (DSTL), for non-ionic surfactant vesicles as drug delivery and targeting systems for antimicrobials on September 28, 2022, under cost-plus-fixed-fee pricing with no set-aside.
Place of performance is Great Britain, United Kingdom. The contract runs through September 27, 2027. The originating solicitation was a Defense Threat Reduction Agency Broad Agency Announcement posted in November 2016, soliciting innovative research and development projects focused on countering weapons of mass destruction across six technology areas at Technology Readiness Levels 2 through 6, with proposals evaluated on technical merit, cost, and transition potential. Work performed under this award addresses advanced antimicrobial drug delivery research within DSTL's core capability area of biotechnology research and development.
Quick answers
Who was awarded contract HDTRA122C0032?
HDTRA122C0032 was awarded to Ministry Of Defence by Defense Threat Reduction Agency (Department of Defense) on September 28, 2022.
How much is contract HDTRA122C0032 worth?
The government has obligated $5,500,449 on HDTRA122C0032. Its current value, with exercised options, is $6,400,449.
Was contract HDTRA122C0032 competed?
The extent of competition for HDTRA122C0032 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award